Search for the autoantibody immunodominant region on thyroid peroxidase: epitopic footprinting with a human monoclonal autoantibody locates a facet on the native antigen containing a highly conformational epitope.
Autoantibodies to thyroid peroxidase (TPO) are the hallmark of the humoral autoimmune response in human autoimmune thyroiditis (Hashimoto's thyroiditis). The majority of TPO autoantibodies in individual patients' sera interact with a restricted immunodominant region on TPO. Although this region can be mapped, previous studies have failed to localize its position on the TPO molecule. We, therefore, used a footprinting approach that can localize a highly conformational, discontinuous epitope on a very large molecule. Extensive biotinylation ( approximately 15 biotins/molecule protein) of lysine residues on the surface of purified, native TPO resulted in loss of multiple tryptic cleavage sites, as determined by analysis of tryptic polypeptide fragments on reverse-phase HPLC. TPO was then complexed with a monoclonal human autoantibody Fab (TR1.9) before biotinylation. After dissociation from TR1.9, TPO was recovered by gel filtration. A trypsin site, previously observed to be lost after TPO biotinylation, was restored when biotinylation was performed on the TPO-TR1.9 complex. The epitope-protected lysine (K) was present in a 30-aa TPO fragment that, by N-terminal sequencing, was found to be K713. Altered recognition by TR1.9 of a TPO-myeloperoxidase chimeric molecule involving this region supported the epitope protection data. In conclusion, we provide the first identification of an amino acid residue (K713) comprising part of an epitope within the TPO immunodominant region. This focal residue localizes the facet on the large, highly complex TPO molecule that contains the immunodominant region and provides the basis for rational guided mutagenesis studies to more fully characterize this region.
Guo
J
J
Autoimmune Disease Unit, Cedars-Sinai Research Institute, and University of California School of Medicine, Los Angeles, CA 90048, USA.
Yan
X M
XM
McLachlan
S M
SM
Rapoport
B
B
D019943:Amino Acid Substitution / Q000276:immunology; D000818:Animals; D000911:Antibodies, Monoclonal / Q000737:chemistry* / Q000378:metabolism; D001323:Autoantibodies / Q000737:chemistry* / Q000378:metabolism; D001324:Autoantigens / Q000737:chemistry* / Q000235:genetics / Q000276:immunology; D019921:Biotinylation; D016466:CHO Cells; D006224:Cricetinae; D018604:Epitope Mapping / Q000379:methods; D005434:Flow Cytometry; D006801:Humans; D006868:Hydrolysis; D016056:Immunodominant Epitopes / Q000302:isolation & purification* / Q000378:metabolism; D007453:Iodide Peroxidase / Q000737:chemistry* / Q000235:genetics / Q000276:immunology* / Q000378:metabolism; D008239:Lysine / Q000378:metabolism; D008958:Models, Molecular; D010446:Peptide Fragments / Q000302:isolation & purification / Q000378:metabolism; D011487:Protein Conformation; D023302:Protein Footprinting; D011994:Recombinant Proteins / Q000737:chemistry / Q000276:immunology; D014357:Trypsin / Q000378:metabolism
D000911:Antibodies, Monoclonal; D001323:Autoantibodies; D001324:Autoantigens; D016056:Immunodominant Epitopes; D010446:Peptide Fragments; D011994:Recombinant Proteins; D007453:Iodide Peroxidase; D014357:Trypsin; D008239:Lysine